
Brain Tumor Diagnosis & Therapeutics Market by Type (Diagnosis, Therapeutics), Indication (Glioblastoma, Meningioma, Pituitary Tumors), Distribution Channel - Global Forecast 2024-2030
Description
Brain Tumor Diagnosis & Therapeutics Market by Type (Diagnosis, Therapeutics), Indication (Glioblastoma, Meningioma, Pituitary Tumors), Distribution Channel - Global Forecast 2024-2030
The Brain Tumor Diagnosis & Therapeutics Market size was estimated at USD 1.63 billion in 2023 and expected to reach USD 1.78 billion in 2024, at a CAGR 9.37% to reach USD 3.06 billion by 2030.
Global Brain Tumor Diagnosis & Therapeutics Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Brain Tumor Diagnosis & Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain Tumor Diagnosis & Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Brain Tumor Diagnosis & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co, Carestream Health, Inc., Eisai Co., Ltd., F. Hoffmann-La Roche AG, Fujifilm Corporation, GE Healthcare Inc., GlaxoSmithKline PLC, Hologic, Inc., Illumina, Inc., Invitae Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Merck & Co. Inc., NantOmics, NeoGenomics Laboratories, Inc., Novartis AG, Oncologica Limited, Pfizer, Inc., S&P Global Inc., Shimadzu Corporation, and Siemens Healthineers AG.
Market Segmentation & Coverage
This research report categorizes the Brain Tumor Diagnosis & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Diagnosis
Cerebral Arteriogram
CT Scan
EEG
Lumbar Puncture
Molecular Testing
MRI
PET-CT Scan
Tissue Sampling
Therapeutics
Chemotherapy
Immunotherapy
Radiation Therapy
Surgery
Targeted Therapy
Indication
Glioblastoma
Meningioma
Pituitary Tumors
Distribution Channel
Offline
Diagnostic Centers
Hospital & Clinics
Retail Pharmacies
Online
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Brain Tumor Diagnosis & Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain Tumor Diagnosis & Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Brain Tumor Diagnosis & Therapeutics Market?
4. What is the market share of the leading vendors in the Brain Tumor Diagnosis & Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Brain Tumor Diagnosis & Therapeutics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Brain Tumor Diagnosis & Therapeutics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of neurological disorders
- 5.1.1.2. Need for tests detecting the presence of tumors
- 5.1.1.3. Research activities in the molecular diagnostics
- 5.1.2. Restraints
- 5.1.2.1. High cost associated with the diagnosis and treatment
- 5.1.3. Opportunities
- 5.1.3.1. Rising healthcare expenditure and the favorable reimbursement policies
- 5.1.3.2. Government initiatives for cancer awareness
- 5.1.4. Challenges
- 5.1.4.1. Side effects associated with brain tumor therapeutics
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Brain Tumor Diagnosis & Therapeutics Market, by Type
- 6.1. Introduction
- 6.2. Diagnosis
- 6.3.1. Cerebral Arteriogram
- 6.3.2. CT Scan
- 6.3.3. EEG
- 6.3.4. Lumbar Puncture
- 6.3.5. Molecular Testing
- 6.3.6. MRI
- 6.3.7. PET-CT Scan
- 6.3.8. Tissue Sampling
- 6.3. Therapeutics
- 6.4.1. Chemotherapy
- 6.4.2. Immunotherapy
- 6.4.3. Radiation Therapy
- 6.4.4. Surgery
- 6.4.5. Targeted Therapy
- 7. Brain Tumor Diagnosis & Therapeutics Market, by Indication
- 7.1. Introduction
- 7.2. Glioblastoma
- 7.3. Meningioma
- 7.4. Pituitary Tumors
- 8. Brain Tumor Diagnosis & Therapeutics Market, by Distribution Channel
- 8.1. Introduction
- 8.2. Offline
- 8.3.1. Diagnostic Centers
- 8.3.2. Hospital & Clinics
- 8.3.3. Retail Pharmacies
- 8.3. Online
- 9. Americas Brain Tumor Diagnosis & Therapeutics Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Brain Tumor Diagnosis & Therapeutics Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Brain Tumor Diagnosis & Therapeutics Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. AstraZeneca PLC
- 13.1.3. Bayer AG
- 13.1.4. Bristol-Myers Squibb Co
- 13.1.5. Carestream Health, Inc.
- 13.1.6. Eisai Co., Ltd.
- 13.1.7. F. Hoffmann-La Roche AG
- 13.1.8. Fujifilm Corporation
- 13.1.9. GE Healthcare Inc.
- 13.1.10. GlaxoSmithKline PLC
- 13.1.11. Hologic, Inc.
- 13.1.12. Illumina, Inc.
- 13.1.13. Invitae Corporation
- 13.1.14. Johnson & Johnson Services, Inc.
- 13.1.15. Koninklijke Philips N.V.
- 13.1.16. Merck & Co. Inc.
- 13.1.17. NantOmics
- 13.1.18. NeoGenomics Laboratories, Inc.
- 13.1.19. Novartis AG
- 13.1.20. Oncologica Limited
- 13.1.21. Pfizer, Inc.
- 13.1.22. S&P Global Inc.
- 13.1.23. Shimadzu Corporation
- 13.1.24. Siemens Healthineers AG
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET RESEARCH PROCESS
- FIGURE 2. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET DYNAMICS
- FIGURE 7. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
- FIGURE 10. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.